New
UPPTHERA
The AI engine Fit Assessment
BetaUPPTHERA develops pharmaceutical technology for drug discovery and development, employing targeted protein degradation platforms, which aligns with the pharma tech central requirement.
Blurb
UPPTHERA is a pharmaceutical company that specializes in drug development using targeted protein degradation technology.
HQ Location
Incheon (South Korea)
Founded
2018
Employees
51 - 200
Total funding raised
$21.95M
Funding Status
Series B, $21.95M, May 18, 2022
UPPTHERA, Inc. is a pharmaceutical venture company aiming for new drug development employing 'targeted protein degradation' technology.